100 mg, Oral solid dosage form,100 mg, Oral solid dosage form

2 trials

Sponsors

Duopharma Biotech Berhad

Conditions

Healthy subjects bioequivalence study SitagliptinHealthy subjects bioequivalence study generic Sitagliptin HCL

Phase 1

Bioequivalence Study of a Generic Sitagliptin Phosphate Tablet 100 mg

Active, not recruitingTCTR20220621004

Duopharma Biotech BerhadHealthy subjects bioequivalence study Sitagliptin

Start: 2020-09-03Target: 28Updated: 2026-08-03

Bioequivalence Study of Generic Sitagliptin HCL Tablet 100 mg

Active, not recruitingTCTR20220628001

Duopharma Biotech BerhadHealthy subjects bioequivalence study generic Sitagliptin HCL

Start: 2020-03-05Target: 30Updated: 2026-08-03